An algorithm for managing warfarin resistance
Olusegun O. Osinbowale, Monzr M. Al Malki, Andrew E. Schade, John R. Bartholomew
Abstract
Open-access reader
Olusegun O. Osinbowale, Monzr M. Al Malki, Andrew E. Schade, John R. Bartholomew
Abstract
Open-access reader
Some patients need higher-than-expected doses of warfarin (Coumadin) to get their international normalized ratio (INR) into the therapeutic range. The cause of warfarin resistance can be either acquired (eg, poor compliance, drug interactions, dietary interactions) or hereditary, but the genetic mechanisms of warfarin resistance are not well understood. This review offers an algorithm for the evaluation of patients with suspected warfarin resistance.
OpenAlex reports 48 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Some patients need higher-than-expected doses of warfarin (Coumadin) to get their international normalized ratio (INR) into the therapeutic range. The cause of warfarin resistance can be either acquired (eg, poor compliance, drug interactions, dietary interactions) or hereditary, but the genetic mechanisms of warfarin resistance are not well understood. This review offers an algorithm for the evaluation of patients with suspected warfarin resistance.
Key concepts: Warfarin, Medicine, Drug resistance, Intensive care medicine, Compliance (psychology), Drug, Algorithm, Pharmacology